{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26852239", "DateCompleted": {"Year": "2016", "Month": "09", "Day": "16"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "02", "Day": "06"}], "ELocationID": ["54", "10.1186/s12906-016-1033-0"], "Language": ["eng"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2016", "Month": "Feb", "Day": "06"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice.", "Pagination": {"StartPage": "54", "MedlinePgn": "54"}, "Abstract": {"AbstractText": ["Fructus mume (F. mume) has been used as a traditional treatment for ulcer, cough, and digestive problems for many years in Asian countries. Previous studies have demonstrated that F. mume extracts alleviate cognitive deficits in rats with chronic cerebral hypoperfusion and in mice with scopolamine treatments. The present experiment was conducted to examine the effects of F. mume on cognitive impairments in 5XFAD transgenic mice with five familial Alzheimer's disease (AD) mutations.", "F. mume was administered daily to 5XFAD mice at 12 weeks of age and continued for 90 days. Cognitive function was evaluated using a spatial memory version of the Morris water maze task, the object/location novelty recognition test, and contextual fear conditioning at 24 weeks of age. To elucidate the possible mechanisms underlying the memory improving effects of F. mume in 5XFAD mice, we examined alterations in hippocampal cholinergic function.", "Vehicle-treated 5XFAD mice exhibited hippocampus-dependent memory impairments compared with non-transgenic littermates, which was reversed in F. mume-treated 5XFAD mice. In addition, reduced hippocampal choline acetyltransferase (ChAT) levels in 5XFAD mice were reversed by F. mume treatment, indicating that F. mume enhances the effects of cholinergic neuronal function.", "F. mume may have therapeutic effects on cognitive impairments in AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul, 143-701, Republic of Korea."}], "LastName": "Park", "ForeName": "Jung-Cheol", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul, 143-701, Republic of Korea."}], "LastName": "Ma", "ForeName": "Jinhua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon, 305-811, Republic of Korea. wkjeon@kiom.re.kr."}], "LastName": "Jeon", "ForeName": "Won Kyung", "Initials": "WK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul, 143-701, Republic of Korea. jshan06@konkuk.ac.kr."}], "LastName": "Han", "ForeName": "Jung-Soo", "Initials": "JS"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "EC 2.3.1.6", "NameOfSubstance": "Choline O-Acetyltransferase"}], "CommentsCorrectionsList": [{"RefSource": "BMC Complement Altern Med. 2016 Oct 31;16(1):426. doi: 10.1186/s12906-016-1414-4", "PMID": "27799047"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Choline O-Acetyltransferase"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cognition Disorders"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fruit"}, {"QualifierName": ["enzymology"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": [], "DescriptorName": "Mice, Transgenic"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prunus"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Liu L, Yuan S, Sun Y, Long Y, Li Y, Niu Y, et al. The possible mechanisms of Fructus Mume pill in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats. J Ethnopharmacol. 2009;126(3):557\u201364. doi: 10.1016/j.jep.2009.08.013.", "ArticleIdList": ["10.1016/j.jep.2009.08.013", "19703546"]}, {"Citation": "Choi HJ, Kang OH, Park PS, Chae HS, Oh YC, Lee YS, et al. Mume Fructus water extract inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages. J Med Food. 2007;10(3):460\u20136. doi: 10.1089/jmf.2006.198.", "ArticleIdList": ["10.1089/jmf.2006.198", "17887939"]}, {"Citation": "Tomimoto H, Ihara M, Wakita H, Ohtani R, Lin JX, Akiguchi I, et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol. 2003;106(6):527\u201334. doi: 10.1007/s00401-003-0749-3.", "ArticleIdList": ["10.1007/s00401-003-0749-3", "13680276"]}, {"Citation": "Tsuchiya M, Sako K, Yura S, Yonemasu Y. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res. 1992;89(1):87\u201392. doi: 10.1007/BF00229004.", "ArticleIdList": ["10.1007/BF00229004", "1601104"]}, {"Citation": "Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res. 1998;792(1):105\u201313. doi: 10.1016/S0006-8993(98)00126-7.", "ArticleIdList": ["10.1016/S0006-8993(98)00126-7", "9593846"]}, {"Citation": "Jeon WK, Ma J, Choi BR, Han SH, Jin Q, Hwang BY, et al. Effects of Fructus mume Extract on MAPK and NF-kappaB Signaling and the Resultant Improvement in the Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion. Evid Based Complement Alternat Med. 2012;2012:450838.", "ArticleIdList": ["PMC3546564", "23346201"]}, {"Citation": "Kim MS, Jeon WK, Lee KW, Park YH, Han JS. Ameliorating Effects of Ethanol Extract of Fructus mume on Scopolamine-Induced Memory Impairment in Mice. Evid Based Complement Alternat Med. 2015;2015:102734.", "ArticleIdList": ["PMC4331472", "25705233"]}, {"Citation": "Paul S, Jeon WK, Bizon JL, Han JS. Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment. Front Aging Neurosci. 2015;7:43.", "ArticleIdList": ["PMC4382969", "25883567"]}, {"Citation": "Selkoe DJ, Schenk D. Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2003;43:545\u201384. doi: 10.1146/annurev.pharmtox.43.100901.140248.", "ArticleIdList": ["10.1146/annurev.pharmtox.43.100901.140248", "12415125"]}, {"Citation": "Park GA, Pappas BA, Murtha SM, Ally A. Enriched environment primes forebrain choline acetyltransferase activity to respond to learning experience. Neurosci Lett. 1992;143(1-2):259\u201362. doi: 10.1016/0304-3940(92)90278-F.", "ArticleIdList": ["10.1016/0304-3940(92)90278-F", "1436676"]}, {"Citation": "Lippa AS, Pelham RW, Beer B, Critchett DJ, Dean RL, Bartus RT. Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging. 1980;1(1):13\u20139. doi: 10.1016/0197-4580(80)90019-6.", "ArticleIdList": ["10.1016/0197-4580(80)90019-6", "7266730"]}, {"Citation": "Dickinson-Anson H, Aubert I, Gage FH, Fisher LJ. Hippocampal grafts of acetylcholine-producing cells are sufficient to improve behavioural performance following a unilateral fimbria-fornix lesion. Neuroscience. 1998;84(3):771\u201381. doi: 10.1016/S0306-4522(97)00543-5.", "ArticleIdList": ["10.1016/S0306-4522(97)00543-5", "9579782"]}, {"Citation": "Choi BR, Kwon KJ, Park SH, Jeon WK, Han SH, Kim HY, et al. Alternations of Septal-hippocampal System in the Adult Wistar Rat with Spatial Memory Impairments Induced by Chronic Cerebral Hypoperfusion. Exp Neurobiol. 2011;20(2):92\u20139. doi: 10.5607/en.2011.20.2.92.", "ArticleIdList": ["10.5607/en.2011.20.2.92", "PMC3213701", "22110366"]}, {"Citation": "Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience. 2008;155(3):626\u201339. doi: 10.1016/j.neuroscience.2008.06.023.", "ArticleIdList": ["10.1016/j.neuroscience.2008.06.023", "18621107"]}, {"Citation": "Contestabile A, Ciani E. The place of choline acetyltransferase activity measurement in the \u201ccholinergic hypothesis\u201d of neurodegenerative diseases. Neurochem Res. 2008;33(2):318\u201327. doi: 10.1007/s11064-007-9497-4.", "ArticleIdList": ["10.1007/s11064-007-9497-4", "17940885"]}, {"Citation": "Christensen DZ, Bayer TA, Wirths O. Intracellular Ass triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(7):1153\u201363. doi: 10.1016/j.neurobiolaging.2008.07.022.", "ArticleIdList": ["10.1016/j.neurobiolaging.2008.07.022", "18771817"]}, {"Citation": "Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, et al. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci. 2002;22(8):3234\u201343.", "ArticleIdList": ["PMC6757538", "11943824"]}, {"Citation": "Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340. doi: 10.1523/JNEUROSCI.1202-06.2006.", "ArticleIdList": ["10.1523/JNEUROSCI.1202-06.2006", "PMC6674618", "17021169"]}, {"Citation": "Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis. 2009;33(2):229\u201335. doi: 10.1016/j.nbd.2008.10.006.", "ArticleIdList": ["10.1016/j.nbd.2008.10.006", "PMC2741400", "19026746"]}, {"Citation": "Ohno M. Failures to reconsolidate memory in a mouse model of Alzheimer\u2019s disease. Neurobiol Learn Mem. 2009;92(3):455\u20139. doi: 10.1016/j.nlm.2009.05.001.", "ArticleIdList": ["10.1016/j.nlm.2009.05.001", "PMC2772829", "19435612"]}, {"Citation": "Devi L, Ohno M. Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS One. 2010;5(9):e12974. doi: 10.1371/journal.pone.0012974.", "ArticleIdList": ["10.1371/journal.pone.0012974", "PMC2944882", "20886088"]}, {"Citation": "Jin Q, Lee C, Lee JW, Lee IS, Lee MK, Jeon WK, et al. Chemical Constituents from the Fruits of Prunus mume. Nat Prod Sci. 2012;18(3):200\u20133."}, {"Citation": "Kanno T, Tsuchiya A, Nishizaki T. Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice. Behav Brain Res. 2014;274C:302\u20136. doi: 10.1016/j.bbr.2014.08.034.", "ArticleIdList": ["10.1016/j.bbr.2014.08.034", "25172181"]}, {"Citation": "Save E, Poucet B, Foreman N, Buhot MC. Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behav Neurosci. 1992;106(3):447\u201356. doi: 10.1037/0735-7044.106.3.447.", "ArticleIdList": ["10.1037/0735-7044.106.3.447", "1616611"]}, {"Citation": "Devi L, Ohno M. PERK mediates eIF2alpha phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(10):2272\u201381. doi: 10.1016/j.neurobiolaging.2014.04.031.", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.04.031", "PMC4127890", "24889041"]}, {"Citation": "Lee KM, Bang J, Kim BY, Lee IS, Han JS, Hwang BY, et al. Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling. BMC Complement. Altern. Med. 2015;15(1):125. doi: 10.1186/s12906-015-0652-1.", "ArticleIdList": ["10.1186/s12906-015-0652-1", "PMC4411748", "25898017"]}, {"Citation": "Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer\u2019s neuropathology. J Alzheimers Dis. 2003;5(1):39\u201348.", "ArticleIdList": ["12590165"]}, {"Citation": "Iversen SD. Behavioural evaluation of cholinergic drugs. Life Sci. 1997;60(13-14):1145\u201352. doi: 10.1016/S0024-3205(97)00059-3.", "ArticleIdList": ["10.1016/S0024-3205(97)00059-3", "9121359"]}, {"Citation": "Tarricone BJ, Simon JR, Li YJ, Low WC. Neural grafting of cholinergic neurons in the hippocampal formation. Behav Brain Res. 1996;74(1-2):25\u201344. doi: 10.1016/0166-4328(95)00144-1.", "ArticleIdList": ["10.1016/0166-4328(95)00144-1", "8851913"]}, {"Citation": "Cassel JC, Duconseille E, Jeltsch H, Will B. The fimbria-fornix/cingular bundle pathways: a review of neurochemical and behavioural approaches using lesions and transplantation techniques. Prog Neurobiol. 1997;51(6):663\u2013716. doi: 10.1016/S0301-0082(97)00009-9.", "ArticleIdList": ["10.1016/S0301-0082(97)00009-9", "9175161"]}, {"Citation": "Cassel JC, Gaurivaud M, Lazarus C, Bertrand F, Galani R, Jeltsch H. Grafts of fetal septal cells after cholinergic immunotoxic denervation of the hippocampus: a functional dissociation between dorsal and ventral implantation sites. Neuroscience. 2002;113(4):871\u201382. doi: 10.1016/S0306-4522(02)00226-9.", "ArticleIdList": ["10.1016/S0306-4522(02)00226-9", "12182893"]}, {"Citation": "Sberna G, Saez-Valero J, Li QX, Czech C, Beyreuther K, Masters CL, et al. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer\u2019s disease. J Neurochem. 1998;71(2):723\u201331. doi: 10.1046/j.1471-4159.1998.71020723.x.", "ArticleIdList": ["10.1046/j.1471-4159.1998.71020723.x", "9681463"]}, {"Citation": "Sberna G, Saez-Valero J, Beyreuther K, Masters CL, Small DH. The amyloid beta-protein of Alzheimer\u2019s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem. 1997;69(3):1177\u201384. doi: 10.1046/j.1471-4159.1997.69031177.x.", "ArticleIdList": ["10.1046/j.1471-4159.1997.69031177.x", "9282941"]}, {"Citation": "Hu W, Gray NW, Brimijoin S. Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem. 2003;86(2):470\u20138. doi: 10.1046/j.1471-4159.2003.01855.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.01855.x", "12871588"]}, {"Citation": "Carroll RT, Lust MR, Emmerling MR. Beta-amyloid levels predict cholinesterase activity in human cerebrospinal fluid. Neuroreport. 1999;10(1):127\u201330. doi: 10.1097/00001756-199901180-00023.", "ArticleIdList": ["10.1097/00001756-199901180-00023", "10094147"]}, {"Citation": "Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging. 2003;24(6):777\u201387. doi: 10.1016/S0197-4580(02)00230-0.", "ArticleIdList": ["10.1016/S0197-4580(02)00230-0", "12927760"]}, {"Citation": "Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer\u2019s disease. Psychopharmacology (Berl) 2005;181(1):145\u201352. doi: 10.1007/s00213-005-2230-6.", "ArticleIdList": ["10.1007/s00213-005-2230-6", "PMC1361685", "15778881"]}, {"Citation": "Cho WH, Park JC, Chung C, Jeon WK, Han JS. Learning strategy preference of 5XFAD transgenic mice depends on the sequence of place/spatial and cued training in the water maze task. Behav Brain Res. 2014;273:116\u201322. doi: 10.1016/j.bbr.2014.07.033.", "ArticleIdList": ["10.1016/j.bbr.2014.07.033", "25078295"]}, {"Citation": "Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334. doi: 10.1016/j.cell.2010.02.016.", "ArticleIdList": ["10.1016/j.cell.2010.02.016", "PMC2873093", "20303880"]}, {"Citation": "Morales I, Guzman-Martinez L, Cerda-Troncoso C, Farias GA, Maccioni RB. Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci. 2014;8:112.", "ArticleIdList": ["PMC4001039", "24795567"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "7", "Day": "1"}, {"Year": "2016", "Month": "2", "Day": "1"}, {"Year": "2016", "Month": "2", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "2", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "2", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["26852239", "PMC4744392", "10.1186/s12906-016-1033-0", "10.1186/s12906-016-1033-0"]}}], "PubmedBookArticle": []}